Receive instant notifications when news about your stocks is posted. Request your 1-week free trial at StreetInsider Premium here.
The company is focused on both increasing Tauri-Gum ™ brand awareness and e-commerce sales
NEW YORK, NY, March 19, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue-generating, diversified life science company, with a proprietary line of CBD – and CBG-infused supplement chewing gums (flavors: pomegranate, blood orange, peach-lemon, pear-bellini, mint, blackcurrant), additional product offerings, as well as an ongoing pharmaceutical development initiative announced today that it has with Coalition Technologies entered into a 6 month agreement (the “Agreement”) to improve Search Engine Optimization (SEO) metrics. The company’s aim is to both increase the brand awareness of its flagship Tauri-Gum ™ and to increase e-commerce sales. Given the more favorable outlook for the macro industry, the company believes the timing is prudent to devote a percentage of its marketing budget to SEO services and strategies.
Additionally, the company is confident that its existing infrastructures will allow it to efficiently and effectively monetize significant future improvements to its SEO metrics. The company also expects its recent decision to increase Tauri-Gum ™ CBD and CBG infusion concentrations (25 mg / piece of gum) will expand its potential e-commerce customer base.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life science company involved in several major business activities and initiatives. The company manufactures and sells several proprietary retail products and product lines that focus primarily on the cannabidiol (“CBD”) and cannabigerol (“CBG”) food market segments. The main Tauri-Gum ™ branded product line consists of a proprietary chewing gum that is kosher, halal and vegan formulated (CBD-infused Tauri-Gum ™ flavors: mint, blood orange, pomegranate) (CBG infused) Tauri-Gum ™ flavors: peach -Lemon, black currant) & (Vitamin C + Zinc “Immune Booster” flavor: Bellini pear). The company’s marketing strategy consists of a wide range of retail customers, dealers and a rapidly growing e-commerce business line (e-commerce website: www.taurigum.com). Further information and inquiries can be found on our company website at http://www.tauriga.com
The company’s retail business is complemented by the ongoing pharmaceutical development initiative. This refers to the development of a proposed pharmaceutical grade version of Tauri-Gum ™ for the management of nausea (specifically designed for the following indication: patients undergoing ongoing chemotherapy). On March 18, 2020, the company announced that it had filed a US provisional patent application for its pharmaceutical version of Tauri-Gum ™. The patent filed with the USPTO is entitled “MEDICATED CBD COMPOSITIONS, MANUFACTURING METHODS AND TREATMENT METHODS”. On December 18, 2020, the company announced that it had entered into a master’s service agreement with CSTI to lead the company’s clinical development efforts.
The company is headquartered in Wappingers Falls, New York. The company also operates two full-time e-commerce fulfillment centers: one in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER – Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect management’s beliefs and beliefs about future events. These forward-looking statements are often indicated by the use of words such as “may,” “will,” “expects,” “anticipates,” “believes,” “hopes,” “believes” or plans and may contain statements about corporate goals and achievement certain company goals and milestones. Forward-looking statements are based on current circumstances and management’s current beliefs with respect to events that have not occurred, that may not occur, or that may have different consequences or timing than now assumed or expected. Actual results could differ materially from those expressed in the forward-looking statements due to known and unknown risks and uncertainties. These are no guarantees of general economic and business conditions, the ability to successfully develop and market products, the consumption habits of consumers and companies, as well as the ability to make successful acquisition and licensing transactions, exchange rate fluctuations and other factors about which Tauriga has little or no knowledge Control has to complete. Many of these risks and uncertainties are discussed in more detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings that may be filed with the Securities and Exchange Commission from time to time. Such forward-looking statements are made only as of the date of this release and Tauriga assumes no obligation to update any forward-looking statements to reflect future events or circumstances. You should not place undue reliance on these forward-looking statements.
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
chief Executive Officer
Mr. Seth M. Shaw
Cell No. (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @ sethsms47
Corp. Website: www.tauriga.com
E-commerce website: www.taurigum.com
Source: Tauriga Sciences